EU antitrust regulators will open an extensive probe into Zimmer's (ZMH.N) $13.4 billion bid for Biomet, concerned that the creation of the world's second-largest orthopedic products group may hurt competition, three people familiar with the matter said on Thursday.
Breaking News
Biomet improved financial performance this quarter, CEO tries to prove skeptics wrong.
Subscribe to VCpost newsletter
Most Popular
